603739 蔚藍生物
按盤價 
11.770 +0.570 (+5.089%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.715 | 4.814 | 4.299 | 10.049 | 10.920 |
| 總資產報酬率 ROA (%) | 0.964 | 2.876 | 2.910 | 7.218 | 7.976 |
| 投入資產回報率 ROIC (%) | 1.177 | 3.481 | 3.455 | 8.896 | 9.525 | 邊際利潤分析 |
| 銷售毛利率 (%) | 44.773 | 46.227 | 43.231 | 46.255 | 48.728 |
| 營業利潤率 (%) | 9.068 | 10.251 | 8.847 | 14.847 | 14.794 |
| 息稅前利潤/營業總收入 (%) | 10.723 | 11.400 | 9.239 | 15.167 | 15.068 |
| 淨利潤/營業總收入 (%) | 6.945 | 8.579 | 7.343 | 13.043 | 12.737 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 69.799 | 85.724 | 86.406 | 78.342 | 83.387 |
| 價值變動淨收益/利潤總額(%) | 8.883 | 12.765 | 3.406 | 4.449 | 4.337 |
| 營業外收支淨額/利潤總額(%) | 0.063 | -0.331 | -0.701 | 0.312 | -1.366 | 償債能力分析 |
| 流動比率 (X) | 1.066 | 1.033 | 1.503 | 2.610 | 2.721 |
| 速動比率 (X) | 0.869 | 0.844 | 1.234 | 2.188 | 2.264 |
| 資產負債率 (%) | 39.882 | 39.837 | 32.764 | 24.133 | 23.164 |
| 帶息債務/全部投入資本 (%) | 30.352 | 27.954 | 22.397 | 10.175 | -- |
| 股東權益/帶息債務 (%) | 222.802 | 249.206 | 336.089 | 848.541 | 4,204.827 |
| 股東權益/負債合計 (%) | 140.709 | 141.336 | 194.654 | 299.252 | 307.574 |
| 利息保障倍數 (X) | 6.504 | 9.637 | 20.368 | 55.576 | 31.861 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 96.070 | 93.284 | 84.607 | 68.229 | 0.000 |
| 存貨周轉天數 (天) | 111.388 | 105.830 | 90.137 | 81.996 | 0.000 |
| 備註： | 即時報價更新時間為 27/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
